Effects of regorafenib on the mononuclear/phagocyte system and how these contribute to the inhibition of colorectal tumors in mice

HIGHLIGHTS

• who: Sylvia Gru00fcnewald from the Bayer AG, Berlin, Germany have published the paper: Effects of regorafenib on the mononuclear/phagocyte system and how these contribute to the inhibition of colorectal tumors in mice, in the Journal: (JOURNAL)
• what: In blood, the analysis focused on the C u00ad D115hiF4/80- population, henceforth referred to as C u00ad D115hi. All available measurements starting from day 15 of the experiment (CT26 study) and from day 14 of the experiment (MC38 study) were used for the evaluation, except for intra-daily observations in the final 24 h. In REG . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.